ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, vol.22, no.14, pp.2607-2618, 2022 (SCI-Expanded)
Background: Pancreatic ductal adenocarcinoma ( PDAC) is the 4th leading cause of cancer deaths in the US due to the lack of effective targeted therapeutics and extremely poor prognosis.